Intermittent Fasting Significantly Reduces Blood Sugar, Insulin, and BMI: What a 12-Study Meta-Analysis Found

Intermittent Fasting Significantly Reduces Blood Sugar, Insulin, and BMI: What a 12-Study Meta-Analysis Found

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

What This Study Looked At

Researchers at Yonsei University wanted to know whether intermittent fasting — across its various forms — meaningfully improved glucose metabolism and body weight compared to control conditions. Rather than conducting a new trial, they pooled data from 12 existing randomized controlled trials, giving them a larger and more statistically robust dataset than any single study could provide.

The analysis directly addresses a question central to millions of people with elevated blood sugar: can changing when you eat — without necessarily changing what or how much — produce measurable improvements in fasting glucose, insulin, and HbA1c? For context on how fasting affects insulin more broadly, see how intermittent fasting improves insulin sensitivity and intermittent fasting and type 2 diabetes.

Who Was Studied

Participant profile: Overweight and obese adults (BMI predominantly 25–35 kg/m²), aged approximately 20–60 years. Some studies included participants with metabolic risk factors; others were in generally healthy overweight adults. Gender distribution varied across trials.

How intermittent fasting worked across the included studies: Protocols varied significantly. The most common were 5:2 (two days of very low calorie intake per week), 16:8 time-restricted eating (eating within an 8-hour window daily), and alternate-day fasting (alternating full-calorie and very-low-calorie days). Study durations ranged from 4 to 24 weeks.

What the Researchers Found

BMI and Body Weight

Intermittent fasting produced a significant reduction in BMI compared to control conditions, with a weighted mean difference of approximately −0.75 kg/m². This was consistent across different IF protocols and study durations.

Fasting Glucose

• Fasting glucose fell significantly in the intermittent fasting groups compared to controls.
• The reduction was present across multiple IF protocols, not limited to a single fasting format.
• The magnitude of blood sugar reduction is clinically meaningful for individuals in the prediabetic range.

Fasting Insulin and Insulin Resistance

• Fasting insulin was significantly reduced in IF groups versus controls, with a weighted mean difference of approximately −0.5 to −0.6 μIU/mL.
• Reduced fasting insulin is a key marker of improved insulin sensitivity — the body needs less insulin to process the same amount of glucose.

HbA1c

• HbA1c showed a reduction in the IF groups, though the magnitude varied across studies.
• A reduction in HbA1c — even a modest one — reflects improved average blood sugar control over the preceding 2–3 months and is the standard clinical benchmark for assessing glycaemic management.

Lipids and Other Markers

• Total cholesterol: Significantly reduced in IF groups, weighted mean difference approximately −0.23 to −0.24 mmol/L.
• LDL cholesterol: Trend toward reduction in several included studies.
• Triglycerides: Reduced in most IF groups.

What Did Not Change

• Lean mass preservation was not consistently reported across included studies and was not a primary meta-analytic outcome.
• Blood pressure results were mixed across included trials.

What the Researchers Concluded

The researchers concluded that intermittent fasting was effective at reducing both BMI and markers of glucose metabolism — specifically fasting glucose, fasting insulin, and HbA1c — compared to control conditions. They noted that IF appeared to be a viable dietary strategy for improving metabolic health, though they acknowledged the heterogeneity of protocols and population characteristics across included trials.

What This Means If You Fast

• Blood sugar improvement is a consistent finding. Across 12 trials and roughly 870 participants, IF reliably reduced fasting glucose and insulin — not just body weight. This matters for anyone with elevated blood sugar, prediabetes, or insulin resistance.
• The protocol matters less than the consistency. Whether 5:2, 16:8, or alternate-day fasting, the pattern of reducing glucose and insulin held across different approaches. Picking a protocol you can sustain may matter more than finding the "optimal" format. See which intermittent fasting protocol is best for beginners for practical guidance.
• Even modest HbA1c reductions are meaningful. A reduction of even 0.1–0.3% in HbA1c can move someone from a prediabetic range into the normal range. For people with elevated but not yet diabetic blood sugar, this is a clinically important change.
• Fasting insulin falling is the real signal. Fasting glucose is what most people track, but fasting insulin is the more sensitive early marker of insulin resistance. IF consistently reduced both in this analysis.
• Short durations produced meaningful results. Several included studies were 8–12 weeks long. You don't need years of fasting to see glucose metabolism improvements — changes can appear within weeks. How long does it take to see results covers the typical timeline.
• Combine with food quality. Fasting alone reduces insulin exposure, but pairing IF with lower carbohydrate, higher protein eating amplifies the glucose-lowering effect significantly. See what to eat during intermittent fasting for food strategy.

Study Limitations

• Heterogeneity of IF protocols: Pooling 5:2, 16:8, ADF, and other formats into a single meta-analysis makes it harder to attribute effects to any specific protocol.
• Short study durations: Most included trials ran 8–24 weeks, limiting conclusions about long-term glucose control and HbA1c normalization.
• Variable comparator groups: Some studies compared IF to continuous calorie restriction (which also reduces blood sugar), others to usual diet — making the effect size estimates context-dependent.
• Population heterogeneity: Participants ranged from generally healthy overweight adults to those with metabolic risk factors; findings may not uniformly apply to all subgroups.
• Limited follow-up: Most trials assessed outcomes immediately post-intervention rather than at 6 or 12 months post-completion.
• Funding and conflicts: Not systematically reported across all included trials.

Source

Cho Y, Hong N, Kim KW, Cho SJ, Lee M, Lee YH, Lee YH, Kang ES, Cha BS, Lee BW. (2019). The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 8(10):1645. PMID: 31601019

Frequently Asked Questions

Does intermittent fasting actually lower blood sugar?

Yes. This meta-analysis of 12 RCTs found that intermittent fasting significantly reduced fasting glucose by approximately 4–5 mg/dL and fasting insulin by about 0.5–0.6 μIU/mL compared to control conditions. These reductions were consistent across different IF protocols.

Which type of intermittent fasting is best for lowering blood sugar?

This meta-analysis included 5:2, 16:8, and alternate-day fasting protocols — and all showed improvement in glucose markers. The evidence does not clearly favour one format over another for blood sugar control. The most important factor is consistency.

Can intermittent fasting reduce HbA1c?

Yes. HbA1c decreased in the IF groups in this meta-analysis, though the size of the reduction varied across studies. Any downward movement in HbA1c reflects improved average blood sugar control over the preceding months and is clinically meaningful in the prediabetic range.

How quickly does intermittent fasting lower blood sugar?

Several studies in this meta-analysis were as short as 8 weeks and still showed significant reductions in fasting glucose and insulin. Meaningful improvements in glucose metabolism can begin within 2–4 weeks of consistent intermittent fasting, particularly when combined with reduced carbohydrate intake.

Is intermittent fasting safe for people with prediabetes?

The studies reviewed in this meta-analysis included overweight adults with elevated metabolic risk markers, and IF consistently improved glucose outcomes without reported serious adverse effects. However, anyone with prediabetes who is on medication or has other health conditions should consult a healthcare professional before starting.

Does BMI reduction alone explain the blood sugar improvement?

Probably not entirely. Some research on early time-restricted eating has shown glucose improvements even when body weight did not change significantly, suggesting the fasting-related drop in insulin and the change in meal timing have direct metabolic effects beyond simply reducing weight.

Related Research and Articles

• Intermittent fasting and metabolism: what science says
• Can intermittent fasting improve insulin sensitivity?
• Does intermittent fasting help with type 2 diabetes?
• Intermittent fasting benefits: the complete science-backed guide
• Intermittent fasting and weight loss: what 50 studies show
• What is the 5:2 intermittent fasting diet?
• What is the 16:8 intermittent fasting protocol?

FastSyncer tracks every fast for you, and a new challenge starts on the 1st of every month — join free on the App Store.

You know what the study found. The app is where you find out whether it holds for you — join free on the App Store.